Show simple record

dc.contributor.authorVyas, Madhusudan
dc.contributor.authorGarett, N.
dc.contributor.authorLim, R.
dc.contributor.authorFagan, J.
dc.date.accessioned2022-03-10T19:39:40Z
dc.date.available2022-03-10T19:39:40Z
dc.date.issued2021-11
dc.identifier.urihttps://hdl.handle.net/10652/5590
dc.description.abstractProstate cancer that has spread beyond the prostate gland and is resistant to castration is a deadly disease that poses a threat to men's health. The current standard of care for metastatic prostate cancer is hormonal manipulation. However, metastatic castration-resistant prostate cancer (mCRPC) remains a significant treatment and management challenge. Recently, the use of lutetium-177 (Lu177) labelled ligands against PSMA was found to be compelling and resulted in an increase in overall patient survival.en_NZ
dc.language.isoenen_NZ
dc.rightsAll rights reserveden_NZ
dc.subjectNew Zealanden_NZ
dc.subjectcancer patientsen_NZ
dc.subjectprostate canceren_NZ
dc.subjecttheranosticsen_NZ
dc.subjectradionuclide therapyen_NZ
dc.subjectLu-177en_NZ
dc.subjectLutetium-177en_NZ
dc.subjectneuroendocrine tumours (NETs)en_NZ
dc.subjectmetastatic castration-resistant prostate cancer (mCRPC)en_NZ
dc.subjectmCRPCen_NZ
dc.titleA first New Zealand study looked at the role of lutetium-177-P SMA I &T in the progression of metastatic castrate-resistant prostate canceren_NZ
dc.typeConference Contribution - Oral Presentationen_NZ
dc.date.updated2022-02-18T13:30:14Z
dc.rights.holderAuthorsen_NZ
dc.subject.marsden3211 Oncology and carcinogenesisen_NZ
dc.subject.marsden320215 Nuclear medicineen_NZ
dc.identifier.bibliographicCitationVyas, M., Garett, N., Lim, R., & Fagan, J. (2021, November). A first New Zealand study looked at the role of lutetium-177-P SMA I &T in the progression of metastatic castrate-resistant prostate cancer. Paper presented at the National ITP Research Symposium 2021, Wellington, New Zealand.en_NZ
unitec.publication.titleNational ITP Research Symposium 2021en_NZ
unitec.conference.titleNational ITP Research Symposium 2021en_NZ
unitec.conference.orgITP Research (N.Z.)en_NZ
unitec.conference.locationWellington, New Zealanden_NZ
unitec.conference.sdate2021-11-25
unitec.conference.edate2021-11-26
unitec.peerreviewedyesen_NZ
dc.contributor.affiliationUnitec Institute of Technologyen_NZ
dc.contributor.affiliationAuckland University of Technologyen_NZ
dc.contributor.affiliationMercy Radiology (Auckland, N.Z.)en_NZ
unitec.identifier.roms67373en_NZ
unitec.institution.studyareaHealth Sciencesen_NZ


Files in this item

Thumbnail

This item appears in

Show simple record